THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018 ...

Royalty Pharma plc has announced that its board of directors has approved a second quarter dividend of $0.22 per Class A ordinary share ... We have seen 1 firms issue buy ratings on the stock ...